Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types

Cancer Science

Volumn 98, Issue 4, 2007, Pages 549-554

  Oh, Yongtaek ^a   Bae, Su Mi ^b   Kim, Yong Wan ^b   Choi, Ho Sun ^c   Nam, Gye Hyun ^d   Han, Se Jun ^e   Park, Choong Hak ^f   Cho, Younglae ^g   Han, Byoung Don ^a   Ahn, Woong Shick ^b,h  

^a 301 Gayang Technotown   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Chonnam National University   (South Korea)

^d Soonchunhyang University   (South Korea)

^e Chosun University   (South Korea)

^f Dankook University   (South Korea)

^g Kyungpook National University   (South Korea)

^h The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSTYRENE;

ARTICLE; ASSAY; CANCER RISK; CONTROLLED STUDY; CROSS REACTION; DNA MICROARRAY; FLUORESCENCE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS TYPING; WART VIRUS;

DNA PROBES, HPV; DNA, VIRAL; FEMALE; FLUORESCENT DYES; GENOTYPE; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 34147109218     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00427.x     Document Type: Article

References (33)

1. Schiffman M, Castle PE. Human papillomavirus: Epidemiology and public health. Arch Pathol Lab Med 2003; 127: 930-4.
2. Vinokurova S, Wentzensen N, Einenkel J et al. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst 2005; 97: 1816-21.
3. Verdon ME. Issues in the management of human papillomavirus genital disease. Am Fam Physician 1997; 55: 1813-20.
4. Johnston C. Quantitative tests for human papillomavirus. Lancet 2000; 355: 2179-80.
5. Meisels A. The story of a cell: The George N. Papanicolaou Award Lecture 23. Acta Cytol 1983; 27: 584-96.
6. Lee KR, Manna EA, St John T. Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagnost Cytopathol 1995; 13: 202-8.
7. Ylitalo N, Sorensen P, Josefsson AM et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study. Lancet 2000; 355: 2194-8.
8. Salvia PN, Bergo SM, Bonesso-Sabadini PI, Tagliarini EB, Hackel C, De Angelo Andrade LA. Correlation between histological criteria and human papillomavirus presence based on PCR assay in cervical biopsies. Int J Gynecol Cancer 2004; 14: 126-32.
9. Farthing A, Masterson PP, Mason WP, Vousden KH. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol 1994; 47: 649-52.
10. Schiffman MH, Kiviat NB, Burk RD et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 1995; 33: 545-50.
11. Jastania R, Geddie WR, Chapman W, Boerner S. Characteristics of apparently false-negative digene hybrid capture 2 high-risk HPV DNA testing. Am J Clin Pathol 2006; 125: 223-8.
12. Seme K, Fujs K, Kocjan BJ, Poljak M. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. J Virol Meth 2006; 134: 252-6.
13. Flagella M, Bui S, Zheng Z et al. A multiplex branched DNA assay for parallel quantitative gene expression profiling. Anal Biochem 2006; 352: 50-60.
14. Jiang HL, Zhu HH, Zhou LF, Chen F, Chen Z. Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system. J Med Microbiol 2006; 55: 715-20.
15. Wallace J, Woda BA, Pihan G. Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J Mol Diagn 2005; 7: 72-80.
16. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006; 44: 504-12.
17. Gheit T, Landi S, Gemignani F et al. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006; 44: 2025-31.
18. O'Leary JJ, Landers RJ, Crowley M et al. Genotypic mapping of HPV and assessment of EBV prevalence in endocervical lesions. J Clin Pathol 1997; 50: 904-10.
19. Czerwenka KF, Schon HJ, Manavi M et al. Reliability of in-situ hybridization of smears and biopsies for papilloma virus genotyping of the uterine cervix. Eur J Clin Chem Clin Biochem 1991; 29: 139-45.
20. Hesselink AT, van den Brule AJ, Brink AA et al. Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer 2004; 102: 11-18.
21. Gravitt PE, Peyton CL, Alessi TQ et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-61.
22. Kosel S, Burggraf S, Mommsen J, Engelhardt W, Olgemoller B. Type-specific detection of human papillomaviruses in a routine laboratory setting -improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. Clin Chem Lab Med 2003; 41: 787-91.
23. Matthews CP, Shera KA, McDougall JK. Genomic changes and HPV type in cervical carcinoma. Proc Soc Exp Biol Med 2000; 223: 316-21.
24. Graham DA, Herrington CS. HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: Relation to numerical chromosome abnormalities. Mol Pathol 2000 ; 53: 201-6.
25. McMurray HR, Nguyen D, Westbrook TF, McAnce DJ. Biology of human papillomaviruses. Int J Exp Path 2001; 82: 15-33.
26. Oh TJ, Kim CJ, Woo SK et al. Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses. J Clin Microbiol 2004; 42: 3272-80.
27. Josefsson A, Livak K, Gyllensten U. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay. J Clin Microbiol 1999; 37: 490-6.
28. Brestovac B, Harnett GB, Smith DW, Frost F, Shellam GR. Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus. J Clin Virol 2005; 33: 116-22.
29. Waterboer T, Sehr P, Michael KM et al. Multiplex human papillomavirus serology based on in situ -purified glutathione S-transferase fusion proteins. Clin Chem 2005; 51: 1845-53.
30. Thuis YN, Campion M, Fox H, Hacker NF. Contemporary experience with the management of vulvar intraepithelial neoplasia. Int J Gynecol Cancer 2000; 10: 223-7.
31. Branca M, Giorgi C, Ciotti M et al. Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer. Eur J Gynaecol Oncol 2006; 27: 215-23.
32. Yoshinouchi M, Hongo A, Nakamura K et al. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. J Clin Microbiol 1999; 37: 3514-17.
33. Anderson M, Handley J, Hopwood L, Murant S, Stower M, Maitland NJ. Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning, and automated sequencing. J Med Virol 1997; 52: 8-13.